IDH2 and glioblastoma: In the cohorts in this study, there was no significant difference in the gender distribution between IDH-mutant and IDH-wildtype GBM cases, thus suggesting that the differential methylation levels of MGMT promoters were indeed caused by different IDH-mutant statuses.